Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
Confronting Hereditary Breast and Ovarian Cancer
This FORCE-endorsed book was written by founder and Executive Director Sue Friedman; geneticist Rebecca Sutphen, MD; and health writer, Kathy Steligo. This book is a comprehensive resource on all topics related to hereditary cancer, genetic testing, and risk-management.
Prostate cancer treatment research studies
Link to PARP inhibitor study for metastatic prostate cancer on clinicaltrials.gov.
Prostate cancer prevention and detection research studies
Link to open clinical trials for prostate cancer prevention and detection through clinicaltrials.gov.
Update on the IMPACT Study and Implications for Men with BRCA Mutations
This March 2012 webinar focused on IMPACT, an international study researching whether screening for prostate cancer in men who carry BRCA mutations leads to an earlier diagnosis and improved survival and whether men who carry these genetic alterations are more likely to develop an aggressive form of the disease.
Response to USPSTF Changes for Prostate Screening
The United States Preventive Services Task Force (USPSTF) recently issued a draft of recommended changes for prostate cancer screening in men. The current draft guidelines recommend against PSA screening for men of any age. FORCE submitted this response to the draft changes.
BRCA in Men
Webcast from 2010 conference session presented by Mary Daly, MD on cancer risks and detection in men with mutations.
BRCA and the Risk of Pancreatic Cancer
Winter 2008 FORCE newsletter article summarizing Dr. Klapman’s presentation at 2008 annual conference on pancreatic cancer in people with BRCA mutations
A Poem for Sari
From Summer 2007 FORCE newsletter, this article is a tribute from a BRCA mutation father to his daughter who carries the same mutation.
H.I.S. Breast cancer Awareness
A nonprofit organization supporting awareness of male breast cancer.